Angiogenic effects of combined gene therapeutic construction pcDNA_VEGF165/Ang-1 in conditions of modeling chronic limb ischemia in vivo
Open Access
- 28 May 2025
- journal article
- Published by Publishing House Belorusskaya Nauka in Proceedings of the National Academy of Sciences of Belarus, Medical series
- Vol. 22 (2) , 95-101
Abstract
The combined plasmid construct pcDNA_VEGF165/Ang-1 has a pronounced angiogenic effect under the conditions of the modeled experimental chronic insufficiency of arterial blood supply to the limb. A single local administration of pcDNA_VEGF165/Ang-1 at a dose of 100 μg into the ischemic skeletal muscle of laboratory animals starting from the 14th day after therapy stimulates the formation of microcirculatory bed vessels with a statistically significant increase in the number of capillaries. The use of the gene therapeutic substance pcDNA_VEGF165/Ang-1 allows for complete restoration of impaired blood supply in the muscles of the thigh and lower leg of the rats by the 28th day of observation, creates conditions for maintaining a long-term positive effect until the end of the experiment (42nd day) while maintaining the number of blood vessels in one muscle fiber not lower than the healthy tissue indicator.Keywords
This publication has 8 references indexed in Scilit:
- Antinociceptive Effectiveness of Use of the Combined VEGF165-ANG-1 Plasmid Construction in Animals with Experimental Hind Limb IschemiaХирургия. Восточная Европа, 2024
- Biological potential of a genetic engineering construction encoding the gene for the human vascular endothelium growth factorProceedings of the National Academy of Sciences of Belarus, Medical series, 2024
- Angiogenic and antinociceptive effects of the genotherapy construction pcDNA_VEGF165 in the conditions of chronic limb ischemia in an in vivo experimentDoklady of the National Academy of Sciences of Belarus, 2024
- Pathogenetic Model of Chronic Arterial Insufficiency of Blood Supply to a Limb in an ExperimentХирургия. Восточная Европа, 2024
- The role of endothelial cell–pericyte interactions in vascularization and diseasesJournal of Advanced Research, 2024
- Gene-based therapies in patients with critical limb ischemiaExpert Opinion on Biological Therapy, 2017
- VEGF gene therapy: therapeutic angiogenesis in the clinic and beyondGene Therapy, 2012
- Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialThe Lancet, 2005